Cited 0 times in
Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.